{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:17:04Z","timestamp":1762431424144},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.aprim.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T22:45:41Z","timestamp":1523659541000},"page":"333-340","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neumon\u00edas adquiridas en la comunidad en pacientes con enfermedad pulmonar obstructiva cr\u00f3nica tratados con corticoides inhalados u otros broncodilatadores. Estudio PNEUMOCORT"],"prefix":"10.1016","volume":"51","author":[{"given":"Rosa","family":"Morros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Vedia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Giner-Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aina","family":"Casellas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Amado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Miguel","family":"Baena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2018.02.007_bib0150","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2018.02.007_bib0155","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of Global Mortality and Burden of Disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PloS Med."},{"key":"10.1016\/j.aprim.2018.02.007_bib0160","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. GOLD 2017. Global Initiative for Chronic Obstructive Lung Disease. 2017."},{"key":"10.1016\/j.aprim.2018.02.007_bib0165","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/thx.2009.115725","article-title":"Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities","volume":"64","author":"Miravitlles","year":"2009","journal-title":"Thorax."},{"key":"10.1016\/j.aprim.2018.02.007_bib0170","unstructured":"Institut Catal\u00e0 de la Salut. ICS. Malaltia pulmonar obstructiva cr\u00f2nica. Guies de pr\u00e0ctica cl\u00ednica. 2010."},{"key":"10.1016\/j.aprim.2018.02.007_bib0175","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(16)31354-X","article-title":"Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial","volume":"388","author":"Singh","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2018.02.007_bib0180","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.rmed.2015.06.006","article-title":"Efficacy and safety of umeclidinium added to fluticasone furoate\/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies","volume":"109","author":"Siler","year":"2015","journal-title":"Respir Med."},{"key":"10.1016\/j.aprim.2018.02.007_bib0185","first-page":"381","article-title":"Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations","volume":"11","author":"Calverley","year":"2016","journal-title":"Int J COPD."},{"key":"10.1016\/j.aprim.2018.02.007_bib0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/rccm.200611-1630OC","article-title":"Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia","volume":"176","author":"Ernst","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.aprim.2018.02.007_bib0195","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2018.02.007_bib0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archinternmed.2008.550","article-title":"Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis","volume":"169","author":"Singh","year":"2009","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.aprim.2018.02.007_bib0205","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax."},{"key":"10.1016\/j.aprim.2018.02.007_bib0210","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/cid\/cit472","article-title":"Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study","volume":"57","author":"Eurich","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.aprim.2018.02.007_bib0215","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/COPD.S115137","article-title":"Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease","volume":"11","author":"Lin","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"10.1016\/j.aprim.2018.02.007_bib0220","unstructured":"AEMPS. Nota informativa: Revisi\u00f3n sobre el riesgo de neumon\u00eda asociado a la administraci\u00f3n de corticoides inhalados para el tratamiento de la EPOC. Agencia espa\u00f1ola de medicamentos; 2016: 1-2."},{"key":"10.1016\/j.aprim.2018.02.007_bib0225","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(09)61250-2","article-title":"Budesonide and the risk of pneumonia: a meta-analysis of individual patient data","volume":"374","author":"Sin","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2018.02.007_bib0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4104\/pcrj.2009.00072","article-title":"Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators","volume":"19","author":"Mapel","year":"2010","journal-title":"Prim Care Respir J."},{"key":"10.1016\/j.aprim.2018.02.007_bib0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1753465816630208","article-title":"Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review","volume":"10","author":"Iannella","year":"2016","journal-title":"Ther Adv Respir Dis."},{"key":"10.1016\/j.aprim.2018.02.007_bib0240","unstructured":"SIDIAP. SIDIAP. Information system for research in Primary Care [Internet] 2017. [consultado 5 May 2016]. Disponible en: http:\/\/www.sidiap.org\/index.php\/es"},{"key":"10.1016\/j.aprim.2018.02.007_bib0245","unstructured":"WHO. ICD-10 Version: 2016 [Internet]. International Statistical Classification of diseases and Related Health Problems 10th Revision. 2016. [consultado 5 May 2016]. Disponible en: http:\/\/apps.who.int\/classifications\/icd10\/browse\/2016\/en"},{"key":"10.1016\/j.aprim.2018.02.007_bib0250","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index 2017 [Internet]. 2017. [consultado 14 May 2016]. Disponible en: http:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"10.1016\/j.aprim.2018.02.007_bib0255","unstructured":"CatSalut. Servei Catal\u00e0 de la Salut. Conjunt m\u00ednim b\u00e0sic de dades (CMBD) [Internet] 2017. [consultado 1 Ene 2017]. Disponible en: http:\/\/catsalut.gencat.cat\/ca\/proveidors-professionals\/registres-catalegs\/registres\/cmbd\/"},{"key":"10.1016\/j.aprim.2018.02.007_bib0260","unstructured":"ICD-9 online [Internet]. [consultado 1 Ene 2017]. Disponible en: http:\/\/www.icd9data.com\/"},{"key":"10.1016\/j.aprim.2018.02.007_bib0265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.rmed.2008.08.006","article-title":"Epidemiology of community-acquired pneumonia in older adults: A population-based study","volume":"103","author":"Vila-Corcoles","year":"2009","journal-title":"Respir Med."},{"key":"10.1016\/j.aprim.2018.02.007_bib0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200707-973OC","article-title":"The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol\/fluticasone propionate or tiotropium bromide","volume":"177","author":"Wedzicha","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.aprim.2018.02.007_bib0275","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010115.pub2","article-title":"Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease","author":"Kew","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2018.02.007_bib0280","doi-asserted-by":"crossref","first-page":"e1723","DOI":"10.1097\/MD.0000000000001723","article-title":"Inhaled corticosteroids increase the risk of pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.aprim.2018.02.007_bib0285","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012066.pub2","article-title":"Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for stable chronic obstructive pulmonary disease","author":"Horita","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2018.02.007_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-016-0191-7","article-title":"Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort","volume":"16","author":"Busch","year":"2016","journal-title":"BMC Pulm Med."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021265671730358X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021265671730358X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T08:17:39Z","timestamp":1559809059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021265671730358X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S021265671730358X"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2018.02.007","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neumon\u00edas adquiridas en la comunidad en pacientes con enfermedad pulmonar obstructiva cr\u00f3nica tratados con corticoides inhalados u otros broncodilatadores. Estudio PNEUMOCORT","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}